Past, present and future of the synthetic immunoadjuvant MDP and its analogs
- 31 December 1978
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (18) , 2183-2186
- https://doi.org/10.1016/0006-2952(78)90074-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-l-alanyl-d-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder miceCellular Immunology, 1978
- Nonspecific activation of murine spleen cells in vitro by a synthetic immunoadjuvant (N-acetyl-muramyl-l-alanyl-d-isoglutamine)Cellular Immunology, 1977
- Current Prospects and Problems for a Malaria VaccineThe Journal of Infectious Diseases, 1977
- Control of Influenza and Poliomyelitis with Killed Virus VaccinesScience, 1977
- Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomersBiochemical and Biophysical Research Communications, 1976
- Modulation of the immunologic response of myelin basic protein by extrinsic and intrinsic factorsNeurology, 1976
- Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble componentsCellular Immunology, 1976
- Total synthesis and adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1975
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- SOME ASPECTS OF ACTIVE IMMUNIZATIONAnnual Review of Microbiology, 1947